SavedAdd your journal

Journals / Journal of Mood Disorders / 2017 / Cilt: 7 - Sayı: 4

Topiramate add-on for treatment of migraine-type headache cures alcohol dependence: a case report

Aysun KALENDEROGLU
Murat Eren OZEN
Oguzhan Bekir EGİLMEZ
Mehmet Hamdi ORUM
Pages
241–242
Publication Date
2022-10-18
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Additionally, the patient’s migrainesymptoms improved, without the appearance of side effects.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Topiramate presents a broad-spectrum efficacy in the treatment of different psychiatric and neurological conditions, assuggested by findings from studies on addiction, epilepsy, and migraine headaches.
📊
Key Findings & Data:Alcohol craving and consumption were significantly reduced.
💡
Conclusion & Impact:Additionally, the patient’s migrainesymptoms improved, without the appearance of side effects.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Topiramate presents a broad-spectrum efficacy in the treatment of different psychiatric and neurological conditions, assuggested by findings from studies on addiction, epilepsy, and migraine headaches. Here, we present a patient with adiagnosis of alcohol dependence that was treated with topiramate for migraine headaches as an add-on treatment topsychiatric medications. Alcohol craving and consumption were significantly reduced. Additionally, the patient’s migrainesymptoms improved, without the appearance of side effects.

🔖

Cite This Article

KALENDEROGLU, A., OZEN, M. E., EGİLMEZ, O. B., ORUM, M. H. (2022). Topiramate add-on for treatment of migraine-type headache cures alcohol dependence: a case report. Journal of Mood Disorders, Cilt: 7 - Sayı: 4, 241–242. https://ajindex.com/articles/564507

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (1)

  1. Arbaizar B, Gomez-Acebo I, Llorca J. Efficacy of topiramate in bulimia nervosa and binge-eating disorder: a systematic review. Gen Hosp Psychiatry. 2008;30(5):471-5. [CrossRef] 2. Johnson BA, Ait-Daoud N, Akhtar FZ, Javors MA. Use of oral topiramate to promote smoking abstinence among alcoholdependent smokers: a randomized controlled trial. Arch Intern Med. 2005;165(14):1600-5. [CrossRef] 3. Jonhson BA, Rosenthal N, Capece JA, Wiegand F, Mao L, Beyers K, et al. Topiramate for treating alcohol dependence: a randomized controlled trial. JAMA. 2007;298(14):1641-51. [CrossRef] 4. Arbaizar B, Dierssen-Sotos T, Gomez-Acebo I, Llorca J. Topiramate in the treatment of alcohol dependence: a meta-analysis. Actas Esp Psiquiatr. 2010;38(1):8-12. 5. Angehagen M, Ronnback L, Hansson E, Ben-Menachem E. Topiramate reduces AMPA-induced Ca(2+) transients and inhibits Glu R1 subunit phosphorylation in astrocytes from primary cultures. J Neurochem. 2005;94(4):1124-30. [CrossRef] 6. White HS, Brown SD, Woodhead JH, Skeen GA, Wolf HH. Topiramate modulates GABA evoked currents in murine cortical neurons by a nonbenzodiazepine mechanism. Epilepsia. 2000;41(Suppl.1):17-20. [CrossRef] 7. Weiss F, Porrino LJ. Behavioral neurobiology of alcohol addiction: recent advances and challenges. J Neurosci. 2002;22(9):3332-7. 8. Johnson BA, Ait-Daoud N, Akhtar FM, Ma JZ. Oral topiramate reduces the consequences of drinking and improves the quality of life of alcohol-dependent individuals: a randomized controlled trial. Arch Gen Psychiatry 2004;61(9):905-12. [CrossRef] 9. De Sousa AA, De Sousa, JA, Kapoor H. An open randomized trial comparing disulfiram and topiramate in the treatment of alcohol dependence. J Subst Abuse Treat. 2008;34(4):460-3. [CrossRef]